Hca Healthcare (HCA) Shareholder Consulta LTD Has Cut Its Stake; Founders Capital Management Position in Johnson & Johnson (JNJ) Has Trimmed as Shares Declined

Johnson & Johnson (NYSE:JNJ) Logo

Founders Capital Management Llc decreased its stake in Johnson & Johnson (JNJ) by 11.37% based on its latest 2018Q4 regulatory filing with the SEC. Founders Capital Management Llc sold 3,643 shares as the company’s stock declined 5.44% while stock markets rallied. The institutional investor held 28,405 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $3.67M, down from 32,048 at the end of the previous reported quarter. Founders Capital Management Llc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $367.52 billion market cap company. The stock decreased 1.00% or $1.39 during the last trading session, reaching $138.02. About 7.70M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 8.80% since March 15, 2018 and is uptrending. It has outperformed by 4.43% the S&P500. Some Historical JNJ News: 17/04/2018 – J&J – QTRLY WORLDWIDE MEDICAL DEVICES SALES $6,767 MLN VS $6,293 MLN REPORTED LAST YR; 16/04/2018 – BRISTOL-MYERS SQUIBB ANNOUNCES WORLDWIDE COLLABORATION WITH JANSSEN TO DEVELOP & COMMERCIALIZE BRISTOL-MYERS’ FACTOR XIA INHIBITOR, BMS-986177; 20/03/2018 – DOMINIC J. CARUSO TO RETIRE AS CFO OF JOHNSON & JOHNSON; 17/04/2018 – J&J SAYS ESTIMATES THAT ABOUT 70% OF CUMULATIVE PRE-TAX COSTS RELATING TO GLOBAL SUPPLY CHAIN ACTIONS WILL RESULT IN CASH OUTLAYS – SEC FILING; 05/05/2018 – New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid lmprovements in Depressive Symptoms in Patients with Treatment-Resistant Depression; 16/04/2018 – Johnson & Johnson expected to post earnings of $2.01 a share – Earnings Preview; 26/04/2018 – Quandl Launches Exclusive Corporate Aviation Intelligence Platform; 07/05/2018 – JANSSEN PHARMA – FDA APPROVAL OF DARZALEX IN COMBINATION WITH BORTEZOMIB, MELPHALAN AND PREDNISONE MARKS ITS FIFTH INDICATION IN MULTIPLE MYELOMA; 24/05/2018 – Drug Overview 2018: lnvega Sustenna/lnvega Trinza (Paliperidone Palmitate; Johnson & Johnson) – ResearchAndMarkets.com; 29/03/2018 – Arkansas sues opioid manufacturers for roles in epidemic

Consulta Ltd decreased its stake in Hca Healthcare Inc (HCA) by 13.33% based on its latest 2018Q4 regulatory filing with the SEC. Consulta Ltd sold 100,000 shares as the company’s stock declined 5.73% while stock markets rallied. The institutional investor held 650,000 shares of the health care company at the end of 2018Q4, valued at $80.89M, down from 750,000 at the end of the previous reported quarter. Consulta Ltd who had been investing in Hca Healthcare Inc for a number of months, seems to be less bullish one the $45.15B market cap company. The stock increased 0.73% or $0.95 during the last trading session, reaching $131.77. About 1.68M shares traded. HCA Healthcare, Inc. (NYSE:HCA) has risen 36.88% since March 15, 2018 and is uptrending. It has outperformed by 32.51% the S&P500. Some Historical HCA News: 01/05/2018 – HCA HEALTHCARE STILL SEES FY REV. $45B TO $46B; 01/05/2018 – HCA HEALTHCARE 1Q ADJ EBITDA $2.12B, EST. $2.10B; 01/05/2018 – HCA Healthcare Latest 1Q Includes $92 Million Tax Benefit; 17/05/2018 – HCA Healthcare’s Gulf Coast Division’s Nations, Kimmel Named HBJ Healthcare Heroes; 13/03/2018 – HCA HEALTHCARE – ENTERED INTO ADDITIONAL JOINDER AGREEMENT WITH NEW APPROXIMATELY $1.166 BLN SENIOR SECURED TERM B-11 LOAN CREDIT FACILITY; 09/04/2018 – Moody’s Cites HCA’s Continued Track Record of Stable Operating Performance and Strong Cash Flow; 27/04/2018 – HCA Healthcare’s Gulf Coast Division Wins Three SETRAC Awards; 09/04/2018 – HCA HEALTHCARE’S CFR TO Ba1 FROM Ba2 BY MOODY’S; 21/03/2018 – HCA Healthcare: Current Far West Division Pres Bryan Rogers to Retire; 08/05/2018 – HCA Healthcare at Deutsche Bank Health Care Conference Tomorrow

Investors sentiment increased to 1.08 in Q4 2018. Its up 0.26, from 0.82 in 2018Q3. It improved, as 37 investors sold HCA shares while 200 reduced holdings. 77 funds opened positions while 178 raised stakes. 247.43 million shares or 5.65% more from 234.20 million shares in 2018Q3 were reported. Ls Invest Advisors Limited Liability Corporation holds 3,349 shares. 2,380 are owned by Capstone Investment Advisors Limited Liability Corporation. Leuthold Grp Llc has 1.99% invested in HCA Healthcare, Inc. (NYSE:HCA). State Treasurer State Of Michigan holds 0.09% or 76,820 shares in its portfolio. 513,056 were reported by Lee Danner And Bass. Centurylink Invest Com stated it has 11,530 shares or 0.67% of all its holdings. Highstreet Asset has 12,726 shares. Hourglass Limited Liability Co accumulated 46,217 shares. Employees Retirement Of Ohio owns 198,898 shares. Mackenzie Corp holds 0% or 5,854 shares in its portfolio. Tekla Cap Lc owns 74,335 shares. Massmutual Tru Com Fsb Adv has 0% invested in HCA Healthcare, Inc. (NYSE:HCA) for 9,993 shares. Cognios Cap Ltd reported 23,788 shares. Quantbot Tech LP accumulated 12,545 shares or 0.15% of the stock. Ftb Advsr reported 0.01% stake.

More notable recent HCA Healthcare, Inc. (NYSE:HCA) news were published by: Businesswire.com which released: “Study at HCA Healthcare Hospitals Shows Significant Reduction in Bloodstream Infections – Business Wire” on March 05, 2019, also Businesswire.com with their article: “HCA Healthcare Appoints Meg Crofton as New Independent Director – Business Wire” published on February 21, 2019, Bizjournals.com published: “HCA board member steps down, will be replaced by former Disney exec – Nashville Business Journal” on February 26, 2019. More interesting news about HCA Healthcare, Inc. (NYSE:HCA) were released by: Globenewswire.com and their article: “Analysis: Positioning to Benefit within Fiserv, Align Technology, The Boeing, RE/MAX, HCA Healthcare, and CoreLogic — Research Highlights Growth, Revenue, and Consolidated Results – GlobeNewswire” published on March 06, 2019 as well as Businesswire.com‘s news article titled: “HCA Healthcare Announces Greg Lowe as President of Newly Created North Carolina Division – Business Wire” with publication date: February 20, 2019.

Since October 31, 2018, it had 0 insider purchases, and 18 selling transactions for $30.48 million activity. 5,196 HCA Healthcare, Inc. (NYSE:HCA) shares with value of $709,358 were sold by Cuffe Michael S.. On Thursday, February 7 the insider CAMPBELL VICTOR L sold $3.90 million. Another trade for 263 shares valued at $36,979 was made by Morrow J William on Thursday, February 7. 5,081 shares were sold by Englebright Jane D., worth $720,994 on Wednesday, November 7. Foster Jon M also sold $4.63 million worth of HCA Healthcare, Inc. (NYSE:HCA) shares. $72,639 worth of stock was sold by Reiner Deborah M on Tuesday, January 29.

Analysts await HCA Healthcare, Inc. (NYSE:HCA) to report earnings on May, 7. They expect $2.31 earnings per share, down 0.86% or $0.02 from last year’s $2.33 per share. HCA’s profit will be $791.50M for 14.26 P/E if the $2.31 EPS becomes a reality. After $2.99 actual earnings per share reported by HCA Healthcare, Inc. for the previous quarter, Wall Street now forecasts -22.74% negative EPS growth.

Investors sentiment decreased to 0.86 in Q4 2018. Its down 0.19, from 1.05 in 2018Q3. It turned negative, as 51 investors sold JNJ shares while 851 reduced holdings. 145 funds opened positions while 631 raised stakes. 1.79 billion shares or 5.17% more from 1.70 billion shares in 2018Q3 were reported. Moreover, Verition Fund Mgmt Lc has 0.33% invested in Johnson & Johnson (NYSE:JNJ). Regions Corp accumulated 477,998 shares or 0.77% of the stock. Shelton Mgmt invested in 35,066 shares. Waters Parkerson & Co Ltd Liability Company has 162,220 shares. Gm Advisory Group invested in 12,074 shares or 0.58% of the stock. Murphy Cap has invested 2.08% in Johnson & Johnson (NYSE:JNJ). Community Bank & Trust Of Raymore has 8,135 shares for 0.43% of their portfolio. France-based Comgest Global Sas has invested 4.76% in Johnson & Johnson (NYSE:JNJ). Bingham Osborn & Scarborough Ltd holds 10,680 shares. 14,073 are owned by S R Schill And Associates. Check Management Ca stated it has 15,200 shares. Fulton Retail Bank Na holds 0.66% or 64,579 shares in its portfolio. Icm Asset Mgmt Wa holds 1.18% or 10,400 shares. The Massachusetts-based Reynders Mcveigh Capital Mngmt Lc has invested 3.8% in Johnson & Johnson (NYSE:JNJ). The Florida-based Camarda Advsrs Limited Com has invested 0.37% in Johnson & Johnson (NYSE:JNJ).

Since November 7, 2018, it had 3 insider purchases, and 6 insider sales for $74.45 million activity. PEREZ WILLIAM D had bought 1,000 shares worth $133,910. On Wednesday, November 7 Duato Joaquin sold $5.77M worth of Johnson & Johnson (NYSE:JNJ) or 40,000 shares. MULCAHY ANNE M also bought $100,050 worth of Johnson & Johnson (NYSE:JNJ) shares. 2,000 shares were bought by PRINCE CHARLES, worth $268,731 on Friday, December 14. On Monday, December 3 the insider Fasolo Peter sold $24.41M. The insider Kapusta Ronald A sold $536,638.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on April, 16. They expect $2.10 EPS, up 1.94% or $0.04 from last year’s $2.06 per share. JNJ’s profit will be $5.59B for 16.43 P/E if the $2.10 EPS becomes a reality. After $1.97 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 6.60% EPS growth.

Founders Capital Management Llc, which manages about $193.00M and $233.31 million US Long portfolio, upped its stake in Fedex Corporation (NYSE:FDX) by 15,139 shares to 44,513 shares, valued at $7.18 million in 2018Q4, according to the filing. It also increased its holding in Walgreens Boots Allianc by 7,749 shares in the quarter, for a total of 162,893 shares, and has risen its stake in Union Pacific Corp (NYSE:UNP).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson (JNJ) Management Presents at Barclays Global Healthcare Conference Call (Transcript) – Seeking Alpha” on March 14, 2019, also Fool.com with their article: “3 Penny Stocks That Could Make You Rich — or Regretful – The Motley Fool” published on March 14, 2019, Seekingalpha.com published: “J&J eyes Missouri Supreme Court ruling – Seeking Alpha” on February 25, 2019. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Streetinsider.com and their article: “Johnson & Johnson (JNJ) to Acquire Auris Health for $3.4 Billion – StreetInsider.com” published on February 13, 2019 as well as Seekingalpha.com‘s news article titled: “Johnson & Johnson: Brace For Impact – Seeking Alpha” with publication date: March 08, 2019.

HCA Healthcare, Inc. (NYSE:HCA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.